Risk of Immunomediated Adverse Events and Loss of Response to Infliximab in Elderly Patients with Inflammatory Bowel Disease: A Cohort Study of the ENEIDA Registry - Concepedia

Concepedia

Publication | Closed Access

Risk of Immunomediated Adverse Events and Loss of Response to Infliximab in Elderly Patients with Inflammatory Bowel Disease: A Cohort Study of the ENEIDA Registry

14

Citations

19

References

2021

Year

Margalida Calafat, Míriam Mañosa, Elena Ricart, Pilar Nos, E Iglesias-Flores, Isabel Vera, Antonio López–Sanromán, Jordi Guardiola, Carlos Taxonera, Miguel Mínguez,

Journal of Crohn s and Colitis

Abstract

Elderly patients with inflammatory bowel disease have a similar risk of developing IFX-related IAEs and LOR to that of younger patients.

References

	Year	Citations

Page 1